Category: Pathfinder LLC.Syndicate content

Zimmer axes jobs to cut costs ahead of med-tech tax | Personnel Moves

March 6, 2012 by Arezu Sarvestani

Zimmer plans cuts and outsourcing at its Warsaw, Ind., headquarters partially to offset the impending burden of a 2.3% medical device tax.

Zimmer logo

Zimmer Holdings (NYSE:ZMH) announced layoffs at its Warsaw, Ind., headquarters, pointing to the expected burden of the medical device tax as partly responsible for some of the losses.

The orthopedics device maker plans to offset the entire burden posed by the impending 2.3% device levy in 2013 through cost-cutting efforts, part of which include layoffs.

Pelvic mesh panel convenes, Patient health records exposed online, SyntheMed and Pathfinder merge | +3

September 9, 2011 by MassDevice staff

The top three medical device stories for September 9, 2011.

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of's coverage highlights our three biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with Massdevice +3.

SyntheMed and Pathfinder become Pathfinder Cell Therapy after merger | Acquisitions Roundup

September 9, 2011 by MassDevice staff

Pathfinder lands on Wall Street as it merges with SyntheMed to form Pathfinder Cell Therapy.


Closing an agreement that’s been in the works since January, SyntheMed, Inc. (OTC:SYMD), a biomaterials company, changed its name to Pathfinder Cell Therapy, after merging with the biotechnology company.

Richard Franklin, who was President & CEO of Pathfinder, will keep his corner office and Joerg Gruber, a former director of SyntheMed will serve as chairman of the board for the newly created company.